Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders
Posted by: The Sumaira Foundation in
Read MoreChoose Your Language:
Posted by: The Sumaira Foundation in
Read MorePosted by: The Sumaira Foundation in
Read MorePosted by: The Sumaira Foundation in
Read MorePosted by: The Sumaira Foundation in
Read MorePosted by: The Sumaira Foundation in
Read MorePosted by: The Sumaira Foundation in
Read MorePosted by: The Sumaira Foundation in
Read MorePosted by: The Sumaira Foundation in
Read MorePosted by: The Sumaira Foundation in
Read MorePosted by: The Sumaira Foundation in
Read More